Wikipedia -WSS

Wikipedia

author：explore 2025-10-02 11:38:19 - browse：573

FDA-Blood Sugar Monitor — The FDA has approved a device from Abbott that continuously monitors diabetics’ blood sugar levels without requiring backup finger prick tests. Abbott Laboratories via AP

U.S. regulators have approved the first continuous blood sugar monitor for diabetics that doesn’t need backup finger prick tests.

Current models require users to test a drop of blood twice daily to calibrate, or adjust, the monitor.

The pain of finger sticks and the cost of testing supplies discourage many people from keeping close tabs on their blood sugar, which is needed to manage insulin use and adjust what they eat.

Abbott’s new FreeStyle Libre Flash Glucose Monitoring System, approved Wednesday by the Food and Drug Administration, uses a small sensor attached to the upper arm. Patients wave a reader device over it to see the current blood sugar level and changes over the past eight hours.

Most of the 30 million Americans with diabetes use standard glucose meters, which require multiple finger pricks each day and only show current sugar level. More-accurate continuous glucose monitoring devices are used by about 345,000 Americans.

Newsletters

Sign up for Morning Rounds

Your daily dose of news in health and medicine.

Please enter a valid email address. Privacy Policy

But most don’t do the finger pricks to calibrate them and may get inaccurate readings, said Dr. Timothy Bailey, who helped test FreeStyle Libre.

“We’re able to lower blood sugar safely” with this technology, said Bailey, director of the Advanced Metabolic Care and Research Institute in California. He receives consulting fees from various diabetes device makers.

Too-high blood sugar levels can damage organs and lead to heart attacks, strokes, blindness and amputations. Very low blood sugar can cause seizures, confusion and loss of consciousness.

Abbott’s device was approved for adults with type 1 or type 2 diabetes and should be available in pharmacies within months. The company, based near Chicago, did not disclose the price of the reader or the sensors.

Abbott’s system can’t be used with an insulin pump, a device worn against the skin that allows users to inject insulin as needed, but the company is planning improvements to eventually enable that.

Rival Medtronic this spring launched a device in which the insulin pump automatically responds to blood sugar changes recorded by the sensor and either withholds or injects insulin as needed.

— Linda A. Johnson

Previous article： How one medical school became remarkably diverse
Next article： Organ transplantation is at a crossroads. Major reform is needed

WSS

Medicare says breakthrough device reimbursement rule to come by summer

Telehealth startups turn to complex chronic diseases

Medicare says breakthrough device reimbursement rule to come by summer

First recipient of genetically engineered pig kidney has died

Vatican is moving ahead with plan to reunite Ukrainian children taken to Russia with their families

How to improve immunocompromised access to mAb treatments

leisure time

Wikipedia

Sign up for Morning Rounds

hotspot

Moonlake's readout produced a cash windfall. Risks remain

A double vaccine crisis is endangering millions of children

New air purifier tech could be key to improving indoor air quality

As Taiwan prepares for anti

Virginia high school admissions case could be legal follow

Hyaluronic acid injections don’t help knee osteoarthritis, study finds

How one medical school became remarkably diverse

Contact tracing may help avoid another lockdown. Can it work in the U.S.?

Medical records are filled with copy

Court strikes down limits on filming of police in Arizona

leisure time

Study: People of West African ancestry at greater risk of cardiac amyloidosis

Google says AlphaFold 3 can map a vast universe of biomolecules

What to know about Saharan dust affecting the US and how it can affect health

Study: Adult vaccinations pay for themselves in societal benefits

Study: People of West African ancestry at greater risk of cardiac amyloidosis

Study: Adult vaccinations pay for themselves in societal benefits

Wikipedia

leisure time

focus

focus